INTERNATIONAL PATENT: SHENZHEN WONDERCEL BIOTECHNOLOGY LIMITED FILES APPLICATION FOR "EUKARYOTIC CELLS EXPRESSING EXOGENOUS INOSINE MONOPHOSPHATE DEHYDROGENASE COMPRISING CHIMERIC ANTIGEN RECEPTOR BINDING TO GUCY2C"

GENEVA, May 3 -- SHENZHEN WONDERCEL BIOTECHNOLOGY LIMITED (Room 301, Building 6, Qianhai Shenzhen-Hong Kong Youth Innovation and Enterpreneur Hub Northern DistrictShenzhen, Guangdong 518054) filed a patent application (PCT/CN2025/129014) for "EUKARYOTIC CELLS EXPRESSING EXOGENOUS INOSINE MONOPHOSPHATE DEHYDROGENASE COMPRISING CHIMERIC ANTIGEN RECEPTOR BINDING TO GUCY2C" on Oct 21, 2025. With publication no. WO/2026/086785, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FAN, Xiaohu (Room 301, Building 6, Qianhai Shenzhen-...